지앤바이오 / GN BIO
GN BIO's KOBDi Score is 11.78 as of Sep 2026, up 0.16 points since Apr 2025; it rose in 1 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 22% of companies in its industry, against 24% in Aug 2026 and 24% in Apr 2025. Its strongest position was 26% (May 2025) and its weakest 22% (Sep 2026).
A year earlier, in Aug 2025, its score was 11.62 and it was ahead of about 24% of companies in its industry.
| Sep 2026 | 11.78 | ahead of 22% |
| Aug 2026 | 11.78 | ahead of 24% |
| Jul 2026 | 11.78 | ahead of 24% |
| Jun 2026 | 11.78 | ahead of 24% |
| May 2026 | 11.78 | ahead of 24% |
| Apr 2026 | 11.78 | ahead of 23% |
| Mar 2026 | 11.78 | ahead of 23% |
| Feb 2026 | 11.78 | ahead of 25% |
| Dec 2025 | 11.78 | ahead of 25% |
| Aug 2025 | 11.62 | ahead of 24% |
| Jul 2025 | 11.62 | ahead of 23% |
| May 2025 | 11.62 | ahead of 26% |
| Apr 2025 | 11.62 | ahead of 24% |
Where is GN BIO located?
GN BIO is registered at 서울특별시 광진구 능동로, South Korea (postal code 13426).
What industry is GN BIO in?
GN BIO belongs to Wholesale & Retail Trade › Pharmacy & Medical Supply Retail › Pharmaceutical and medical supply retail.
How many employees does GN BIO have?
GN BIO has 1–4 employees.
What is GN BIO's KOBDi Score?
11.78 as of September 2026, ahead of about 22% of companies in its industry.
Who are GN BIO's competitors?
Similar companies include 장생약국, 우리약국 and 바다약국.